LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | barcode | cell_count | frac_dead | corpse_count | cell_count_dead | row | column | agent | concentration | role | timepoint | replicate | cell_line | dead_count | fraction_dead | cell_count__time0 | dead_count__time0 | cell_count__ctrl | dead_count__ctrl | fraction_dead__ctrl | increase_fraction_dead | GRvalue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dasatinib | 180622_MC_14 | 18834 | 0.0179 | 73 | 265 | 10 | 17 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_2 | 338 | 0.0176 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00644 | 0.9824 |
| Dasatinib | 180622_MC_14 | 18171 | 0.0180 | 42 | 285 | 12 | 4 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_3 | 327 | 0.0177 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00639 | 0.9645 |
| Dasatinib | 180622_MC_15 | 17831 | 0.0203 | 69 | 295 | 10 | 17 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_4 | 364 | 0.0200 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00406 | 0.9552 |
| Dasatinib | 180622_MC_15 | 17872 | 0.0154 | 55 | 221 | 10 | 18 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_5 | 276 | 0.0152 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00886 | 0.9563 |
| Dasatinib | 180622_MC_15 | 17610 | 0.0162 | 56 | 230 | 13 | 18 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_6 | 286 | 0.0160 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00809 | 0.9491 |
| Dasatinib | 180622_MC_16 | 19144 | 0.0244 | 69 | 400 | 6 | 19 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_7 | 469 | 0.0239 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00015 | 0.9906 |
| Dasatinib | 180622_MC_16 | 18113 | 0.0281 | 160 | 353 | 9 | 3 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_8 | 513 | 0.0275 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | 0.00347 | 0.9630 |
| Dasatinib | 180622_MC_16 | 17653 | 0.0212 | 84 | 292 | 11 | 19 | Dasatinib | 0.003326667 | treatment | 72 | 3 | MCF10A-GM_9 | 376 | 0.0209 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00321 | 0.9503 |
| Dasatinib | 180622_MC_14 | 19136 | 0.0219 | 79 | 341 | 9 | 14 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_1 | 420 | 0.0215 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00259 | 0.9904 |
| Dasatinib | 180622_MC_14 | 16553 | 0.0205 | 60 | 280 | 12 | 9 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_2 | 340 | 0.0201 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00394 | 0.9188 |
| Dasatinib | 180622_MC_14 | 17437 | 0.0284 | 92 | 406 | 13 | 3 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_3 | 498 | 0.0278 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | 0.00370 | 0.9442 |
| Dasatinib | 180622_MC_15 | 17412 | 0.0192 | 75 | 260 | 5 | 15 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_4 | 335 | 0.0189 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00519 | 0.9435 |
| Dasatinib | 180622_MC_15 | 18375 | 0.0207 | 70 | 311 | 8 | 20 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_5 | 381 | 0.0203 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00375 | 0.9701 |
| Dasatinib | 180622_MC_15 | 17838 | 0.0211 | 87 | 292 | 9 | 15 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_6 | 379 | 0.0208 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00326 | 0.9554 |
| Dasatinib | 180622_MC_16 | 17448 | 0.0258 | 141 | 313 | 7 | 12 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_7 | 454 | 0.0254 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | 0.00129 | 0.9445 |
| Dasatinib | 180622_MC_16 | 17970 | 0.0227 | 130 | 280 | 9 | 10 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_8 | 410 | 0.0223 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00176 | 0.9590 |
| Dasatinib | 180622_MC_16 | 17941 | 0.0268 | 141 | 344 | 9 | 11 | Dasatinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_9 | 485 | 0.0263 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | 0.00225 | 0.9582 |
| Dasatinib | 180622_MC_14 | 16998 | 0.0244 | 79 | 337 | 8 | 21 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_1 | 416 | 0.0239 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00018 | 0.9317 |
| Dasatinib | 180622_MC_14 | 16240 | 0.0203 | 68 | 263 | 11 | 16 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_2 | 331 | 0.0200 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00409 | 0.9096 |
| Dasatinib | 180622_MC_14 | 15735 | 0.0153 | 33 | 209 | 12 | 18 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_3 | 242 | 0.0151 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00892 | 0.8944 |
| Dasatinib | 180622_MC_15 | 16038 | 0.0207 | 84 | 249 | 3 | 7 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_4 | 333 | 0.0203 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00373 | 0.9036 |
| Dasatinib | 180622_MC_15 | 16579 | 0.0158 | 78 | 185 | 6 | 15 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_5 | 263 | 0.0156 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00845 | 0.9196 |
| Dasatinib | 180622_MC_15 | 17223 | 0.0201 | 100 | 249 | 8 | 18 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_6 | 349 | 0.0199 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | -0.00421 | 0.9382 |
| Dasatinib | 180622_MC_16 | 17777 | 0.0289 | 144 | 374 | 3 | 8 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_7 | 518 | 0.0283 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | 0.00425 | 0.9537 |
| Dasatinib | 180622_MC_16 | 16988 | 0.0268 | 127 | 332 | 3 | 17 | Dasatinib | 0.033266667 | treatment | 72 | 3 | MCF10A-GM_8 | 459 | 0.0263 | 1252.0 | 97.6 | 19505 | 481.8 | 0.0241 | 0.00224 | 0.9314 |